Münch, J., Bachmann, A., & Kirschfink, M. (2017). Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies. Clinical kidney journal, 10(6), . https://doi.org/10.1093/ckj/sfx053
Chicago Style (17th ed.) CitationMünch, Johannes, Anette Bachmann, and Michael Kirschfink. "Effective Immunosuppressive Management with Belatacept and Eculizumab in Post-transplant AHUS Due to a Homozygous Deletion of CFHR1/CFHR3 and the Presence of CFH Antibodies." Clinical Kidney Journal 10, no. 6 (2017). https://doi.org/10.1093/ckj/sfx053.
MLA (9th ed.) CitationMünch, Johannes, et al. "Effective Immunosuppressive Management with Belatacept and Eculizumab in Post-transplant AHUS Due to a Homozygous Deletion of CFHR1/CFHR3 and the Presence of CFH Antibodies." Clinical Kidney Journal, vol. 10, no. 6, 2017, https://doi.org/10.1093/ckj/sfx053.